Mr Mrs Miss Ms Dr Other

Mr
Michael
Nelson

Partner & European and UK Patent Attorney

Basel Office

Chemistry

Telephone. +41(0) 61 225 4480
Mobile. +41(0) 78 698 8690
Email. [email protected]

Experience

Michael is a specialist patent attorney in the in the pharmaceutical field and has more than 20 years of experience at all stages of a product, from early phase discovery to defending marketed pharmaceutical products. Michael acts for a wide range of clients including multinationals, SMEs, universities and research organisations.

Prior to joining HGF Michael worked "in-house" as a patent attorney for 13 years for AstraZeneca and use this experience and insight to advise clients and develop IP strategies that are focused on their commercial objectives.

His work covers patent drafting, global prosecution, patent term extensions and SPCs, freedom to operate analysis and opinions, regulatory exclusivity as well as significant experience in IP due diligence evaluation. Michael also handles EPO oppositions and appeals for his clients.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

Physics (First Class Honours)

Publications

HGF & Shiga Webinar Recording: When "Please amend to fall into line with the granted claims in the US" might not work in Europe and Japan

View publication online

EU Draft legislation on SPCs released

View publication online

Opposition case studies

View publication online

Swiss Institute for Translational and Entrepreneurial Medicine

View publication online

Conferences: 2022

June 27th 2022

Webinar: A comparison of IP Practice in EU, US and JP for new medical use and method of treatment patenting

Speaker

Event details

Conferences: 2021

May 10th 2021

Intellectual Property - Are you protecting your business ideas?

Speaker

Event details

Conferences: 2020

March 3rd 2020

IP in Healthcare Conference 2020

Speaker

Event details

Conferences: 2019

June 27th 2019

Update on the CRISPR IP Saga and lessons to be learnt - Basel

Speaker

Event details

March 14th 2019

IP in Healthcare Conference 2019 - London & Manchester

Speaker

Event details

Related News

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

How to Use IP Strategy to Tip the Odds in Your Favour

Porter’s Five Forces model [1] is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …

Read article

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.